gabexate has been researched along with thromboxane b2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higuchi, E; Kamiyama, S; Kato, K; Kumaki, S; Kume, K; Nozawa, R; Ohara, N; Suzuki, J; Suzuki, S; Yugeta, E | 1 |
| Bulbena, O; Closa, D; Fernandez-Cruz, L; Gelpi, E; Hotter, G; Martrat, A; Rosello-Catafau, J | 1 |
2 other study(ies) available for gabexate and thromboxane b2
| Article | Year |
|---|---|
Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Esters; Gabexate; Guanidines; Male; Nephrosis; Protease Inhibitors; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thromboxane B2 | 1988 |
Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Amylases; Animals; Ceruletide; Epoprostenol; Gabexate; Lipase; Male; Pancreatitis; Phospholipases A; Phospholipases A2; Rats; Rats, Sprague-Dawley; Taurocholic Acid; Thromboxane A2; Thromboxane B2 | 1993 |